Cholangioscopic appearance of circular folds in immune-related adverse event cholangitis

Endoscopy 2022; 54(12): E722-E723
DOI: 10.1055/a-1756-4388

E-Videos

Authors

Ko Tomishima

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan
Shigeto Ishii

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan
Toshio Fujisawa

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan
Satoshi Sakuma

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan
Yusuke Takasaki

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan
Koichi Ito

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan
Hiroyuki Isayama

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan

References
1 Kawakami H, Tanizaki J, Tanaka K. et al. Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer. Invest New Drugs 2017; 35: 529-536
2 Kuraoka N, Hara K, Terai S. et al. Peroral cholangioscopy of nivolumab-related (induced) ulcerative cholangitis in a patient with non-small cell lung cancer. Endoscopy 2018; 50: E259-E261
3 Hashimoto Y, Kumahara K, Ueda Y. et al. Cholangioscopic finding of severe hemorrhagic cholangitis associated with immune-related adverse events. Gastrointest Endosc 2021; 94: 859-860